Cytek Biosciences Reports Third Quarter 2024 Financial Results

Go back to Cytek Biosciences Reports Third Quarter 2024 Financial Results
(NASDAQ: CTKB) Delayed: 4.70 --0 (-0%)
Previous Close $4.70    52 Week High
Open $4.63    52 Week Low
Day High $4.78    P/E N/A 
Day Low $4.62    EPS
Volume 306,994